228 related articles for article (PubMed ID: 28165585)
1. Hepatitis C virus infection in maintenance hemodialysis patients: recommendations for diagnostics and treatment.
Dzekova-Vidimliski P; Sikole A
Int J Artif Organs; 2017 Feb; 39(12):590-595. PubMed ID: 28165585
[TBL] [Abstract][Full Text] [Related]
2. New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
Fabrizi F; Martin P; Messa P
Kidney Int; 2016 May; 89(5):988-994. PubMed ID: 27083277
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis.
Li T; Qu Y; Guo Y; Wang Y; Wang L
Liver Int; 2017 Jul; 37(7):974-981. PubMed ID: 27943605
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis.
Toyoda H; Kumada T; Tada T; Takaguchi K; Ishikawa T; Tsuji K; Zeniya M; Iio E; Tanaka Y
J Gastroenterol; 2016 Jul; 51(7):741-7. PubMed ID: 26872889
[TBL] [Abstract][Full Text] [Related]
5. Direct-acting antivirals for hepatitis C virus in patients on maintenance dialysis.
Fabrizi F; Donato FM; Messa P
Int J Artif Organs; 2017 Oct; 40(10):531-541. PubMed ID: 28708211
[TBL] [Abstract][Full Text] [Related]
6. Current Status of Hepatitis C Virus-Infected Maintenance Hemodialysis Patients in Japan.
Abe T; Oomori S; Obara W
Ther Apher Dial; 2018 Feb; 22(1):58-60. PubMed ID: 29071791
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C Treatment in Chronic Kidney Disease Patients: The Kidney Disease Improving Global Outcomes Perspective.
Jadoul M; Martin P
Blood Purif; 2017; 43(1-3):206-209. PubMed ID: 28114144
[TBL] [Abstract][Full Text] [Related]
8. Development of Interferon-Free, Direct-Acting Antivirals Treatment for Japanese Patients with Chronic Hepatitis C Infection and Chronic Kidney Disease.
Atsukawa M; Kondo C; Kawano T; Okubo T; Arai T; Nakagawa-Iwashita A; Itokawa N; Iwakiri K
J Nippon Med Sch; 2021 Jun; 88(3):163-170. PubMed ID: 33692289
[TBL] [Abstract][Full Text] [Related]
9. [Current status of the prevalence, diagnosis, and treatment of hepatitis C in patients undergoing hemodialysis].
Yang GL; Lei XZ
Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):233-236. PubMed ID: 28482415
[TBL] [Abstract][Full Text] [Related]
10. Sofosbuvir-based treatment is safe and effective in Indian hepatitis C patients on maintenance haemodialysis: A retrospective study.
Akhil MS; Kirushnan B; Martin M; Arumugam K; Ganesh Prasad NK; Ravichandran R
Nephrology (Carlton); 2018 May; 23(5):446-452. PubMed ID: 28339162
[TBL] [Abstract][Full Text] [Related]
11. A review of direct-acting antivirals for the treatment of hepatitis C in patients with advanced chronic kidney disease.
Maruyama A; Partovi N; Yoshida EM; Erb SR; Azalgara VM; Hussaini T
Nephrol Dial Transplant; 2017 Jan; 32(1):35-41. PubMed ID: 26481484
[TBL] [Abstract][Full Text] [Related]
12. Management of hepatitis C in patients with chronic kidney disease.
Carvalho-Filho RJ; Feldner AC; Silva AE; Ferraz ML
World J Gastroenterol; 2015 Jan; 21(2):408-22. PubMed ID: 25593456
[TBL] [Abstract][Full Text] [Related]
13. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.
Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM
Virol J; 2015 Feb; 12():8. PubMed ID: 25644891
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of naturally occurring protease inhibitor resistance-associated variants in hemodialysis and renal transplant patients with hepatitis C virus infection.
Tavares RCF; Feldner ACCA; Pinho JRR; Uehara SNO; Emori CT; Carvalho-Filho RJ; Silva ISS; Santana RAF; de Castro VFD; Castoli GTF; Cristovão CU; Ferraz MLCG
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):754-758. PubMed ID: 28234637
[TBL] [Abstract][Full Text] [Related]
15. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
Vallet-Pichard A; Pol S
Nephrol Ther; 2015 Nov; 11(6):507-20. PubMed ID: 26423779
[TBL] [Abstract][Full Text] [Related]
16. [Sofosbuvir and daclatasvir combination therapy in hemodialysis patient with liver transplantation].
Hachicha M; Botta-Fridlund D
Nephrol Ther; 2016 Dec; 12(7):536-538. PubMed ID: 27825643
[TBL] [Abstract][Full Text] [Related]
17. Antiviral treatment and prognosis in patients undergoing maintenance hemodialysis due to hepatitis C virus.
Zhang W; Yuan Q; Ning J; Li X; Wu A; Xiao X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1332-1337. PubMed ID: 35232901
[TBL] [Abstract][Full Text] [Related]
18. Acute hepatitis C in patients receiving hemodialysis.
Griveas I; Germanidis G; Visvardis G; Morice Y; Perelson AS; Pawlotsky JM; Papadopoulou D
Ren Fail; 2007; 29(6):731-6. PubMed ID: 17763169
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and Management of Hepatitis C Infection in Primary Care Settings.
Guss D; Sherigar J; Rosen P; Mohanty SR
J Gen Intern Med; 2018 Apr; 33(4):551-557. PubMed ID: 29352420
[TBL] [Abstract][Full Text] [Related]
20. Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study.
Kikuchi K; Akiba T; Nitta K; Masakane I; Ando R; Izumi N; Atsukawa M; Yamazaki C; Kato F; Hotta N; Tominaga Y; Orito E; Hora K; Nagasawa M; Kasahara H; Kawaguchi M; Kimura H; Ikebe N; Kawanishi H; Moriishi M; Shigemoto K; Harada T; Hirakata H; Watanabe H; Nosaki T; Tsubouchi H; Imawari M; Akizawa T
Ther Apher Dial; 2014 Dec; 18(6):603-11. PubMed ID: 25196061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
